Microbiome Movement Oncology Response is a conference dedicated to harnessing and translating the microbiome to improve identification of patient responders.
Microbiome Movement Oncology Response covers topics such as:
How –omics data are being integrating to inform cancer clinical decision making
The mechanistic pathways underpinning the causality of the microbiome in cancer and consequential effects of cancer therapeutics on microbial dysbiosis
The nutritional interventions for cancer treatment and prevention
Translational applications of the microbiome in cancer 1) to improve clinical safety outcomes, 2) as a validated biomarker to predict patient response and 3) as an LBP monotherapy or adjuvant to enhance therapeutic efficacy (particularly in the context of immunotherapy)
How to integrate the microbiome into existing oncology medical practice and drug development infrastructures
Clinical experience to establish gold standards for cancer clinical trials incorporating the microbiome as a measurable endpoint